Tatjana Traub-Weidinger

PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group.

M. J. van den Bent, N. Galldiks, N. Tolboom, 2024, The Lancet. Oncology.

Theranostics in Neurooncology: Heading Toward New Horizons.

N. Tolboom, M. Glas, D. Van Weehaeghe, 2023, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy

N. Tolboom, D. Van Weehaeghe, Francesco Fraioli, 2024, European journal of nuclear medicine and molecular imaging.

FAPi PET/CT for assessment and visualisation of active myositis-related interstitial lung disease: a prospective observational pilot study

S. Blüml, I. Gessl, O. Kulterer, 2024, EClinicalMedicine.

EANM perspectives for CZT SPECT in brain applications.

N. Tolboom, L. Imbert, D. Van Weehaeghe, 2024, European journal of nuclear medicine and molecular imaging.

Results from a phase I study of 4-l-[131I]iodo-phenylalanine ([131I]IPA) with external radiation therapy in patients with recurrent glioblastoma (IPAX-1)

J. Pichler, A. Braat, Patrick Flamen, 2024, Neuro-oncology advances.

Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0

M. J. van den Bent, N. Galldiks, N. Tolboom, 2024, European journal of nuclear medicine and molecular imaging.